Why is Samrat Pharma falling/rising?

As of 28-Oct, Samrat Pharmachem Ltd's stock price is currently at 275.60, reflecting a decrease of 9.2 points or 3.23%. The stock has recently hit a new 52-week low of Rs. 272.1 and has been on a downward trend, experiencing a consecutive fall over the last two days with a total decline of 6.64%. Additionally, the stock has underperformed its sector by 2.97% today. Over the past week, the stock has decreased by 8.98%, and it has shown significant underperformance over longer periods, with a year-to-date decline of 27.86% and a one-year decline of 39.43%. There is a notable increase in investor participation, with delivery volume rising by 216.82% against the 5-day average, indicating some interest despite the falling price.
Broader market context shows that while Samrat Pharmachem Ltd is experiencing a decline, the benchmark Sensex has gained 0.24% over the past week. This stark contrast highlights the stock's underperformance relative to the broader market. The stock is trading below its moving averages across various time frames, suggesting a bearish trend. The liquidity of the stock appears adequate for trading, as it is based on 2% of the 5-day average traded value. Overall, the combination of hitting a new low, underperformance against the sector and benchmark, and the ongoing downward price movement contributes to the current decline in Samrat Pharmachem Ltd's stock price.